Jonathann Kuo, MD A maintenance protocol is a different conversation than a titration
Glucagon-like peptide-1 (GLP-1) receptor agonists represent a class of medications increasingly prescribed for type 2 diabetes management and, more recently, for weight management in adults with obesity
Aim for at least 8 to 10 cups of water daily, and consume foods or drinks with sodium and potassium during early treatment weeks
The landmark FLOW trial demonstrated that semaglutide reduced the risk of significant kidney events by 24% compared to placebo in patients with type 2 diabetes and chronic kidney disease
There is no robust evidence base guiding treatment in the 25-27 range, and essentially no data for BMIs below 25
SGLT-2 inhibitors have many benefits, such as improving glycated hemoglobin levels, promoting weight loss, lowering blood pressure, and protecting kidney function